Homology, Unum set IPO terms; Knight pays Ardelyx $19M for tenapanor rights in Canada
→ Two biotechs in Boston have set the terms for their IPOs: Homology Medicines plans to raise $100 million by offering 6.7 million shares between …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
